2016 Press Releases

Keyword Search
 
2016 | 2015 | 2014 | 2013 | 2012
DateTitle 
11/29/16Cipher Pharmaceuticals Announces Plans to Voluntarily Delist from NASDAQ
MISSISSAUGA, ON, Nov. 29, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (TSX:CPH; NASDAQ:CPHR) ("Cipher" or "the Company") today announced that its Board of Directors has approved the voluntary withdrawal of its common shares from NASDAQ and the voluntary de-registration of its common shares under the U.S. Securities Exchange Act. Cipher's common shares will continue trading on the Toronto Stock Exchange ("TSX"), where the Company has been listed since 2004. "Consistent with our commitment... 
Printer Friendly Version
11/11/16Cipher Pharmaceuticals Reports Q3 2016 Financial Results
MISSISSAUGA, ON, Nov. 11, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company") today announced its financial and operational results for the three months ended September 30, 2016. Unless otherwise noted, all figures are in U.S. currency. Financial Highlights for Q3 2016 (all figures compared to Q3 2015, unless otherwise noted) Total revenue of $9.3 million, an increase of 10% from $8.5 million in Q3 2015. Licensing revenue of $6.8 milli... 
Printer Friendly Version
11/11/16Cipher Pharmaceuticals Announces Management Change
MISSISSAUGA, ON, Nov. 11, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company") today announced that Stephen L. Lemieux, Chief Financial Officer and Secretary of the Company, has been named Interim Chief Executive Officer, replacing Shawn O'Brien, who is pursuing other opportunities. Cipher has commenced a formal search process for a new Chief Executive Officer. "With his extensive public company and operational experience, we are highly confident... 
Printer Friendly Version
10/31/16Cipher Pharmaceuticals Responds to Request for Comment from IIROC
MISSISSAUGA, ON, Oct. 31, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company"), in response to a request for comment from Investment Industry Regulatory Organization of Canada ("IIROC") and an article which appeared today in Reuters, announced that the Company is working with an advisor to consider various strategic alternatives potentially available to enhance shareholder value, with a focus on the U.S. business. The advisor was engaged as part of t... 
Printer Friendly Version
10/27/16Notice of Cipher Pharmaceuticals Inc. Q3 2016 Conference Call
MISSISSAUGA, ON, Oct. 27, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) today announced it will host a conference call for its Q3 2016 financial results on Friday, November 11, 2016. Q3 2016 CONFERENCE CALL WHEN: Friday, November 11, 2016 at 8:30AM ET CONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450 or 1-888-231-8191. A live audio webcast will be available through www.cipherpharma.com or http://bit.ly/2ekaMxk.  An archived replay of the we... 
Printer Friendly Version
09/01/16Cipher Pharmaceuticals appoints Stephen Lemieux as Chief Financial Officer
Company also announces appointment of Dr. John Mull as Chair of the Board of Directors MISSISSAUGA, ON, Sept. 1, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company") today announced that Stephen L. Lemieux, BA, MMPA, CPA, has been appointed Chief Financial Officer and Secretary of the Company, effective September 12, 2016.  Mr. Lemieux replaces Norman Evans, who, as previously announced, is retiring after almost 10 years as the Chief Financial... 
Printer Friendly Version
08/10/16Cipher Pharmaceuticals Reports Q2 2016 Results Highlighted by 32% Revenue Growth and $3.1 Million Cash from Operations
MISSISSAUGA, ON, Aug. 10, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company") today announced its financial and operational results for the three months ended June 30, 2016. Unless otherwise noted, all figures are in U.S. currency. Q2 2015 financial information includes results of U.S. operations starting April 13, 2015, the date of the Innocutis acquisition. "It was a solid second quarter for the Company, highlighted by 32% revenue growth and a... 
Printer Friendly Version
08/09/16Cipher Pharmaceuticals Inc. Announces Changes to its Board of Directors
MISSISSAUGA, ON, Aug. 9, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ: CPHR; TSX:CPH) ("Cipher") today announced certain changes to its board of directors (the "Board"). As previously disclosed, a special committee of the Board (the "Special Committee") was established to address the issues of the type referred to in an early warning report filed on July 5, 2016 by 1207407 Ontario Limited, a company wholly-owned by Dr. John D. Mull. The Special Committee, after communications wi... 
Printer Friendly Version
08/03/16Cipher Pharmaceuticals Announces Preliminary Q2 2016 Results Highlighted by 30+% Revenue Growth and $3.0+million Cash from Operations
MISSISSAUGA, ON, Aug. 3, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company") today announced preliminary estimates of its financial results for the three months ended June 30, 2016. The complete financial statements for the Company's second quarter will be released on August 10, 2016, followed by a conference call with management. These preliminary financial results are subject to completion of the Company's customary quarterly closing and review pr... 
Printer Friendly Version
07/20/16Notice of Cipher Pharmaceuticals Inc. Q2 2016 Conference Call
MISSISSAUGA, ON, July 20, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) today announced it will host a conference call for its Q2 2016 financial results on Wednesday, August 10, 2016. Q2 2016 CONFERENCE CALL WHEN: Wednesday, August 10, 2016 at 8:30AM ET CONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450 or 1-888-231-8191. A live audio webcast will be available through www.cipherpharma.com or http://bit.ly/29SSbts. An archived replay of the w... 
Printer Friendly Version
<< First | Previous | Next | Last >>